The diagnostic properties of hs-cTn were dependent on the patients’ background CVD risk as assessed by the NORRISK2-score, and hs-cTnI provided some reclassification abilities, mainly by downgrading the risk attributed to patients without obstructive CAD. The gene discussed is TNNI3; the disease is coronary artery disorder.